• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON GRIESHABER AG GRIESHABER MAXGRIP REVOLUTION DSP FORCEPS; FORCEPS, OPHTHALMIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON GRIESHABER AG GRIESHABER MAXGRIP REVOLUTION DSP FORCEPS; FORCEPS, OPHTHALMIC Back to Search Results
Catalog Number 705.13P
Medical Device Problem Code Difficult to Open or Close (2921)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/18/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A customer reported that an ophthalmic forceps worked initially as expected then became stuck in the closed position during vitreoretinal surgery.An alternate forceps was obtained in order to successfully complete the procedure.There was no harm to the patient.
 
Additional Manufacturer Narrative
Sample received in opened original packaging including cover foil.A review of the device history record traceable to the reported lot number indicates that the product was processed and released according to the product¿s acceptance criteria.The received forceps sample was visually inspected with the aid of a photomicroscope with various magnifications.It shows surgery residuals.After cleaning, it was found that the tube is loose which block the forceps from activating.The customer¿s complaint was confirmed.No glue residuals on the lose tube were visible.The assembly process of the instrument ensure a 100% control of the instrument in production.Additionally a final quality check (qc) inspection is performed.This ensures that the instrument worked well after the production process.However, the root cause for the failure cannot be determined anymore, since the treatment of the instrument during use has a significant influence to glued interface.Root cause was unable to verify.Why the tube was loose and blocked the forceps from activating could not be determined.This device passed the 100% control and was conform when leaving the production.This complaint has been reviewed and future data will be monitored for evidence of adverse trending and further action will be taken, as appropriate.At a minimum, this will include completing reviews of complaint class report levels on a monthly basis.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GRIESHABER MAXGRIP REVOLUTION DSP FORCEPS
Common Device Name
FORCEPS, OPHTHALMIC
Manufacturer (Section D)
ALCON GRIESHABER AG
winkelriedstrasse 52
schaffhausen 8203
SZ  8203
Manufacturer (Section G)
ALCON GRIESHABER AG
winkelriedstrasse 52
schaffhausen 8203
SZ   8203
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key12820140
Report Number3003398873-2021-00086
Device Sequence Number5568494
Product Code HNR
UDI-Device Identifier07612717070721
UDI-Public07612717070721
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 03/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/31/2024
Device Catalogue Number705.13P
Device Lot Number13RR1V
Was Device Available for Evaluation? Device Returned to Manufacturer
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/21/2021
Supplement Date Received by Manufacturer03/04/2022
Initial Report FDA Received Date11/16/2021
Supplement Report FDA Received Date03/25/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/04/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-